Biotech News

CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

CRISPR Therapeutics (CRSP)CRISPR TherapeuticsConference / presentation

ZUG, Switzerland and BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026 at 10:00 a.m. GMT.

Related news

CRISPR Therapeutics

Gene-Based Medicine Platform CRISPR Therapeutics develops gene-edited medicines across hemoglobinopathies, cardiovascular disease, autoimmune disease, oncology, regenerative medicine and rare disease. Its toolkit includes CRISPR/Cas9, the SyNTase editing platform, lipid-nanoparticle delivery and engineered cell therapies. CASGEVY CASGEVY...

Recent company news

Stock data

Close
38.93 USD
Market cap
5.02B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States